FWTFX
Price
$42.19
Change
+$0.46 (+1.10%)
Updated
Jun 2 closing price
Net Assets
4B
RNPCX
Price
$72.62
Change
-$0.43 (-0.59%)
Updated
Jun 3 closing price
Net Assets
164.3B
Interact to see
Advertisement

FWTFX vs RNPCX

Header iconFWTFX vs RNPCX Comparison
Open Charts FWTFX vs RNPCXBanner chart's image
FWTFX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
FWTFX vs. RNPCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWTFX is a Buy and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 164B vs. FWTFX (4B). RNPCX pays higher dividends than FWTFX: RNPCX (0.70) vs FWTFX (0.07). FWTFX was incepted earlier than RNPCX: FWTFX (17 years) vs RNPCX (24 years). FWTFX (1.32) is less costly to investors than RNPCX (1.05). FWTFX is a more actively managed with annual turnover of: 144.00 vs. RNPCX (23.00). FWTFX has a lower initial minimum investment than RNPCX: FWTFX (0) vs RNPCX (250). FWTFX annual gain was more profitable for investors over the last year : 25.49 vs. RNPCX (13.50). RNPCX (16.18) and FWTFX (16.10) have equivalent 5 years return.
FWTFXRNPCXFWTFX / RNPCX
Total Expense Ratio1.321.05126%
Annual Report Gross Expense Ratio1.321.05126%
Fund Existence17 years24 years-
Gain YTD19.1957.221266%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4B164B2%
Annual Yield % from dividends0.070.7010%
Returns for 1 year25.4913.50189%
Returns for 3 years52.1342.59122%
Returns for 5 years16.1016.18100%
Returns for 10 years93.43110.7384%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFS22.250.41
+1.88%
Provident Financial Services
CEPF10.330.02
+0.16%
Cantor Equity Partners IV Inc.
INVH28.87-0.23
-0.79%
Invitation Homes
GRWG1.71-0.02
-0.87%
GrowGeneration Corp
MTNB0.77-0.11
-12.16%
Matinas Biopharma Holdings Inc